Brugia | |
---|---|
B. malayi from blood smear using Giemsa stain. | |
Scientific classification | |
Domain: | Eukaryota |
Kingdom: | Animalia |
Phylum: | Nematoda |
Class: | Chromadorea |
Order: | Rhabditida |
Family: | Onchocercidae |
Genus: | Brugia Buckley, 1960 |
Species | |
Brugia malayi Contents |
Brugia is a genus for a group of small roundworms. They are among roundworms that cause the parasitic disease filariasis. [1] Specifically, of the three species known, Brugia malayi and Brugia timori cause lymphatic filariasis in humans; and Brugia pahangi and Brugia patei infect domestic cats, dogs and other animals. [2] [3] They are transmitted by the bite of mosquitos. [4]
The first species discovered was B. malayi. It was reported by a Dutch parasitologist Steffen Lambert Brug in 1927 from Southeast Asia (Malaya, for which the name was given). It was originally believed to be similar or closely related to another filarial roundworm then named Microfilaria bancrofti (now Wuchereria bancrofti ), described by an English naturalist Thomas Spencer Cobbold in 1877. It was for this reason that Brug gave the original name Microfilaria (Filaria) malayi. Brug was aware of the difference mainly on the basis of their occurrence. He found both the worms in Sumatra, Java, Borneo, and Celebes; but in New Guinea only W. bancrofti was present, but not the new species. [5] They are so similar that even after a decade of research, there were still arguments of B. malayi as a separate and valid species. As such S. Sundar Rao and P.A. Maplestone assigned the name Wuchereria malayi in 1940. [6] The scientific name was retained for two decades. [7]
When a new species (now called Brugia pahangi) was discovered in 1956 from dog and cat, J. J. C. Buckley and J. F. B. Edeson named it Wuchereria pahangi after the village Pahang in Malay, where it was discovered. [8] Another species Wuchereria patei was described by Buckley, with G. S. Nelson and R. B. Heisch, in 1958. It was discovered from cats and dogs in Pate Island, Kenya. [9] Buckley reexamined all the Wuchereria species in 1960, and concluded that the genus should contain only W. bancrofti. He created a new genus Brugia in honour of the original discoverer, thus renaming B. malayi, B. pahangi, and B. patei. [10] In 1977, a new species B. timori was reported from Flores Island in Indonesia. [11]
Brugia roundworms are small, measuring less than a centimetre. The longest female is 60 mm long and 0.19 mm wide, and male is 25 mm long and 0.1 mm wide. [10] Like other roundworms, the females are larger and longer than the males. The young ones called microfilariae are less than half a millimetre. They are enclosed in a sheath (egg shell) which are easily stained with Giemsa stain (but not for B. timori). [11] The sheath protects them while moving in the blood stream. [12] Species of Brugia are similar to W. bancrofti and Loa loa . But they can be differentiated from their smaller microfilariae, complex spicules, and fewer caudal papillae (typically 11, while it is 24 in W. bancrofti). [10]
Brugia roundworms complete their life cycle in two different hosts. Mosquitos are the intermediate host in which the young larvae develop, and thus they are also the vectors of filariasis. Different species of Mansonia and Aedes act as the intermediate hosts. [13] Humans (for B. malayi and B. timori), and animals (for B. pahangi and B. patei) acts as the definitive hosts in which the adult worms cause filariasis. The infective larvae called L3 (third stage) larvae are transmitted by an infected mosquito onto the skin of the definitive host. Once reaching the blood stream, they grow into adult roundworms. Male and female worms reproduce to release the young worms called microfilariae. These microfilariae move to peripheral blood stream from where they are picked up by another mosquito. Inside the mosquito, they became larvae, first L1 and then L3. The L3 larvae are stored in the proboscis from where they are ejected into the host during biting. [14] [15]
Diethylcarbamazine is a medication used in the treatment of filariasis including lymphatic filariasis, tropical pulmonary eosinophilia, and loiasis. It may also be used for prevention of loiasis in those at high risk. While it has been used for onchocerciasis, ivermectin is preferred. It is taken by mouth.
Filariasis, is a filarial infection caused by parasitic nematodes (roundworms) spread by different vectors. They are included in the list of neglected tropical diseases.
Wuchereria bancrofti is a filarial (arthropod-borne) nematode (roundworm) that is the major cause of lymphatic filariasis. It is one of the three parasitic worms, together with Brugia malayi and B. timori, that infect the lymphatic system to cause lymphatic filariasis. These filarial worms are spread by a variety of mosquito vector species. W. bancrofti is the most prevalent of the three and affects over 120 million people, primarily in Central Africa and the Nile delta, South and Central America, the tropical regions of Asia including southern China, and the Pacific islands. If left untreated, the infection can develop into lymphatic filariasis. In rare conditions, it also causes tropical pulmonary eosinophilia. No vaccine is commercially available, but high rates of cure have been achieved with various antifilarial regimens, and lymphatic filariasis is the target of the World Health Organization Global Program to Eliminate Lymphatic Filariasis with the aim to eradicate the disease as a public-health problem by 2020. However, this goal was not met by 2020.
Albendazole is a broad-spectrum antihelmintic and antiprotozoal agent of the benzimidazole type. It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases.
Brugia malayi is a filarial (arthropod-borne) nematode (roundworm), one of the three causative agents of lymphatic filariasis in humans. Lymphatic filariasis, also known as elephantiasis, is a condition characterized by swelling of the lower limbs. The two other filarial causes of lymphatic filariasis are Wuchereria bancrofti and Brugia timori, which both differ from B. malayi morphologically, symptomatically, and in geographical extent.
Dirofilaria immitis, also known as heartworm or dog heartworm, is a parasitic roundworm that is a type of filarial worm, a small thread-like worm, and which causes dirofilariasis. It is spread from host to host through the bites of mosquitoes. Four genera of mosquitoes transmit dirofilariasis, Aedes, Culex, Anopheles, and Mansonia. The definitive host is the dog, but it can also infect cats, wolves, coyotes, jackals, foxes, ferrets, bears, seals, sea lions and, under rare circumstances, humans.
Brugia pahangi is a parasitic roundworm belonging to the genus Brugia. It is a filarial nematode known to infect the lymph vessels of domestic cats and wild animals, causing a disease filariasis.
Lymphatic filariasis is a human disease caused by parasitic worms known as filarial worms. Usually acquired in childhood, it is a leading cause of permanent disability worldwide, impacting over a hundred million people and manifesting itself in a variety of severe clinical pathologies While most cases have no symptoms, some people develop a syndrome called elephantiasis, which is marked by severe swelling in the arms, legs, breasts, or genitals. The skin may become thicker as well, and the condition may become painful. Affected people are often unable to work and are often shunned or rejected by others because of their disfigurement and disability.
In population ecology, density-dependent processes occur when population growth rates are regulated by the density of a population. This article will focus on density dependence in the context of macroparasite life cycles.
Mansonella perstans is a filarial (arthropod-borne) nematode (roundworm), transmitted by tiny blood-sucking flies called midges. Mansonella perstans is one of two filarial nematodes that causes serous cavity filariasis in humans. The other filarial nematode is Mansonella ozzardi. M. perstans is widespread in many parts of sub-Saharan Africa, parts of Central and South America, and the Caribbean.
Mansonelliasis is the condition of infection by the nematode Mansonella. The disease exists in Africa and tropical Americas, spread by biting midges or blackflies. It is usually asymptomatic.
Brugia timori is a filarial (arthropod-borne) nematode (roundworm) which causes the disease "Timor filariasis", or "Timorian filariasis". While this disease was first described in 1965, the identity of Brugia timori as the causative agent was not known until 1977. In that same year, Anopheles barbirostris was shown to be its primary vector. There is no known animal reservoir host.
The microfilaria is an early stage in the life cycle of certain parasitic nematodes in the family Onchocercidae. In these species, the adults live in a tissue or the circulatory system of vertebrates. They release microfilariae into the bloodstream of the vertebrate host. The microfilariae are taken up by blood-feeding arthropod vectors. In the intermediate host the microfilariae develop into infective larvae that can be transmitted to a new vertebrate host.
The Onchocercidae are a family of nematodes in the superfamily Filarioidea. This family includes some of the most devastating human parasitic diseases, such as lymphatic filariasis, onchocerciasis, loiasis, and other filariases.
The Filarioidea are a superfamily of highly specialised parasitic nematodes. Species within this superfamily are known as filarial worms or filariae. Infections with parasitic filarial worms cause disease conditions generically known as filariasis. Drugs against these worms are known as filaricides.
Culex quinquefasciatus, commonly known as the southern house mosquito, is a medium-sized mosquito found in tropical and subtropical regions of the world. It is a vector of Wuchereria bancrofti, avian malaria, and arboviruses including St. Louis encephalitis virus, Western equine encephalitis virus, Zika virus and West Nile virus. It is taxonomically regarded as a member of the Culex pipiens species complex. Its genome was sequenced in 2010, and was shown to have 18,883 protein-coding genes.
Tropical pulmonary eosinophilia, is characterized by cough, bronchospasm, wheezing, abdominal pain, and an enlarged spleen. Occurring most frequently in the Indian subcontinent and Southeast Asia, TPE is a clinical manifestation of lymphatic filariasis, a parasitic infection caused by filarial roundworms that inhabit the lymphatic vessels, lymph nodes, spleen, and bloodstream. Three species of filarial roundworms, all from the Onchocercidae family, cause human lymphatic filariasis: Wuchereria bancrofti, Brugia malayi, and Brugia timori.
Pylore Krishnaier Rajagopalan was an Indian vector control scientist, biologist and acarologist, known for his pioneering contributions to the control programmes against vector-borne diseases in India. He was a former director of the Indian Council of Medical Research managed Vector Control Research Centre, Pondicherry. He graduated in 1949 from the Banaras Hindu University and obtained a Masters in Zoology with University First Rank there itself in 1951. In 1952 he joined the fledgling Virus Research Centre in Pune, and worked under the supervision of some of the finest vector control specialists such as Dr T Ramachandra Rao. In recognition of his outstanding work as a young research scientist, in 1957 he was awarded a Fellowship by the Rockefeller Foundation to pursue a Master's program in Public Health from the University of California. He went on to secure a Diploma in Acarology from the University of Maryland at College Park.
Armigeres (Armigeres) subalbatus is a species complex of zoophilic mosquito belonging to the genus Armigeres. It is found in Sri Lanka, India, Bangladesh, Myanmar, Pakistan, Nepal, Japan, China, Korea, Taiwan, Ryukyu-Retto, Indochina, Thailand, and Guam.
Lymphatic filariasis in India refers to the presence of the disease lymphatic filariasis in India and the social response to the disease. In India, 99% of infections come from a type of mosquito spreading a type of worm through a mosquito bite. The treatment plan provides 400 million people in India with medication to eliminate the parasite. About 50 million people in India were carrying the worm as of the early 2010s, which is 40% of all the cases in the world. In collaboration with other countries around the world, India is participating in a global effort to eradicate lymphatic filariasis. If the worm is eliminated from India then the disease could be permanently eradicated. In October 2019 the Union health minister Harsh Vardhan said that India's current plan is on schedule to eradicate filariasis by 2021.